Daily Newsletter

01 November 2023

Daily Newsletter

01 November 2023

Ortho Development introduces partial knee replacement system

The BKS Uni system offers surgeons a medial fixed-bearing system of instruments and implants.

RanjithKumar Dharma November 01 2023

US-based Ortho Development has expanded its Balanced Knee implant system product line with the introduction of the BKS Uni partial knee replacement system.

The system has been developed to simplify surgical techniques, preserve bone and leverage the Balanced Knee System clinical heritage.

Ortho Development president Brent Bartholomew said: “The launch of BKS Uni builds on Ortho Development's heritage of evolutionary innovation.

“We've created simple, intuitive implants and instruments to aid in streamlining workflow and make a technically demanding surgery more predictable.”

The system offers a medial fixed-bearing system of instruments and implants to surgeons.

These tools are engineered to facilitate intraoperative adjustments, enabling accurate and balanced unicompartmental knee arthritis treatment.

BKS Uni, along with the company’s other Balanced Knee solutions, enables surgeons to treat a range of pathologies, from partial knee replacements to the latest revision procedures using cones and sleeves.

Honolulu’s Straub Medical Center orthopaedic surgeon Dr Cass Nakasone said: “The BKS Uni is an intuitively and instrumentally simple system that allows surgeons to adjust the flexion gap to match the created extension gap or vice versa.

“The simple instrumentation allows surgeons with varying levels of experience with unicondylar knee arthroplasty to achieve efficient and consistent surgical outcomes.”

Ortho Development is focused on designing, manufacturing and distributing orthopaedic implants and related surgical instruments. It mainly focuses on offering total knee and hip joint replacement solutions.

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close